Compare StocksLH vs PFE

Labcorp Holdings Inc. (LH) vs Pfizer, Inc. (PFE): Which Is the Better Buy in 2026?

As of 2026-08-03, LH is overvalued at $309, with a DCF intrinsic value of $213 and a margin of safety of -45%. PFE is undervalued at $25, with an intrinsic value of $127985960274 and a margin of safety of 100%. Of the two, PFE has the wider margin of safety.

LH
Labcorp Holdings Inc.
$309.20
VS
PFE
Pfizer, Inc.
$25.01

Rewards

LH
    PFE
    • Gross margin of 74.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
    • Trailing P/E of 19.1x is 37% below the historical average of 30.4x — potentially undervalued relative to its own history.

    Risks

    LH
    • 18 insider sales with no purchases over the past 12 months — a persistent pattern of insider selling.
    • Free cash flow has declined at a 7.6% CAGR over the past 4 years — a concerning trend.
    PFE
    • ROIC has declined by 15.9 percentage points over the past 4 years, which may signal competitive erosion.
    • PEG ratio of 2.94 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
    • Altman Z-Score of 1.38 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.

    Key Valuation Metrics

    Learn more →
    LH
    PFE
    Valuation
    $1.21B
    Free Cash Flow
    $12.38B
    4.82%
    FCF Yield
    N/A
    25.57
    Trailing P/E
    19.09
    15.65
    Forward P/E
    8.85
    Quality & Moat
    9.02%
    ROIC
    10.19%
    11.73%
    ROE
    8.31%
    28.88%
    Gross Margin
    74.80%
    1.31
    PEG Ratio
    2.94
    Balance Sheet Safety
    0.77
    Net Debt / Equity
    0.57
    N/A
    Interest Coverage
    N/A
    2.86
    Net Debt / EBITDA
    2.03
    0.93%
    Dividend Yield
    6.88%
    LH: 2Ties: 1PFE: 8
    LHPFE

    Historical Fundamentals

    Learn more →
    LH

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    PFE

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

    $1 Retained Earnings Test

    Learn more →
    LH
    $2.13
    created per $1 retained over 3 years
    Exceptional Value Creator
    Σ Retained
    $1.30B
    Δ Market Cap
    +$2.78B
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
    PFE
    N/A
    Net losses over 3 years — test not applicable
    Company had negative cumulative retained earnings
    Σ Retained
    $-10.61B
    Δ Market Cap
    $-26.34
    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
    > $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

    Discounted Cash Flow (DCF) Analysis

    Learn more →
    LH
    44.9% Overvalued
    Price is 44.9% above estimated fair value
    Current Price: $309.20
    Fair Value: $213.39
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued
    PFE
    100.0% Margin of Safety
    Price is 100.0% below estimated fair value
    Current Price: $25.01
    Fair Value: $127985960274.09
    Strongly undervalued
    Undervalued
    Fairly valued
    Overvalued
    Strongly overvalued

    Reverse DCF — Market-Implied Growth

    Learn more →
    LH

    What growth rate is the market pricing in at $309?

    +12.4%
    Market-Implied Owner Earnings Growth
    Standard FCF implies +11.4%

    The market implies +12.4% Owner Earnings growth, above historical trends.

    Standard FCF implies a demanding +11.4%, reflecting heavy growth investment.

    PFE

    What growth rate is the market pricing in at $25?

    -14.2%
    Market-Implied Owner Earnings Growth
    Standard FCF implies -15.0%

    The market implies -14.2% Owner Earnings growth, above historical trends.

    Standard FCF implies a demanding -15.0%, reflecting heavy growth investment.

    Economic Moat Score

    Learn more →
    LH
    52/100
    Narrow Moat
    70+ Wide · 40-69 Narrow · <40 None

    Narrow moat with revenue predictability as the key competitive advantage. Improving roic consistency would strengthen the moat.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
    PFE
    35/100
    No Moat
    70+ Wide · 40-69 Narrow · <40 None

    No durable moat detected, though reinvestment efficiency shows some competitive positioning. The business lacks consistent evidence of sustainable advantages.

    Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

    Forensic Accounting

    Learn more →
    LH
    -2.55
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
    PFE
    -2.53
    Unlikely Manipulator
    Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

    M-Score Trend

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

    Ownership Breakdown

    Learn more →
    LH
    Insiders 0.4%Institutions 102.4%
    No. of Institutional Holders1,406
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
    PFE
    Insiders 0.1%Institutions 69.5%Retail & Other 30.4%
    No. of Institutional Holders3,661
    High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

    High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

    Insider Buying Activity

    Learn more →
    LH
    0
    Buys (3M)
    0
    Buys (12M)
    No open market insider purchases found.
    Open market purchases · includes direct & indirect ownership · excludes option exercises
    PFE
    0
    Buys (3M)
    0
    Buys (12M)
    BLAYLOCK RONALD E
    Director
    $499,072
    @ $25.65 · 2025-02-13
    GOTTLIEB SCOTT
    Director
    $28,240
    @ $28.24 · 2024-10-30
    Open market purchases · includes direct & indirect ownership · excludes option exercises

    Open market purchases · includes direct & indirect ownership · excludes option exercises.

    Insider Selling Activity

    Learn more →
    LH
    4
    Sells (3M)
    18
    Sells (12M)
    Total value (12M): $13.10M
    KYLE KATHRYN W
    Officer
    $26,329
    @ $286.18 · 2026-07-02
    VAUGHN BRYAN T
    Officer
    $66,968
    @ $286.19 · 2026-07-02
    KYLE KATHRYN W
    Officer
    $201,084
    @ $263.89 · 2026-06-08
    SCHECHTER ADAM H
    Chief Executive Officer
    $1.50M
    @ $254.50 · 2026-05-11
    MELTZER JONATHAN C
    Officer
    $224,055
    @ $267.05 · 2026-03-27
    WILKINSON PETER J
    Officer
    $436,093
    @ $267.05 · 2026-03-27
    SCHECHTER ADAM H
    Chief Executive Officer
    $2.44M
    @ $279.96 · 2026-03-03
    VAN DER VAART SANDRA DILLARD
    Officer
    $156,000
    @ $285.19 · 2026-02-27
    CAVENEY BRIAN J
    Officer
    $429,458
    @ $286.31 · 2026-02-24
    WILKINSON PETER J
    Officer
    $185,108
    @ $277.94 · 2026-02-19
    MELTZER JONATHAN C
    Officer
    $25,267
    @ $290.43 · 2026-02-12
    SCHECHTER ADAM H
    Chief Executive Officer
    $1.50M
    @ $284.38 · 2026-02-11
    MELTZER JONATHAN C
    Officer
    $25,188
    @ $276.79 · 2026-02-10
    MELTZER JONATHAN C
    Officer
    $24,247
    @ $275.53 · 2026-02-09
    SCHECHTER ADAM H
    Chief Executive Officer
    $1.51M
    @ $262.75 · 2025-11-11
    PARHAM RICHELLE P
    Director
    $1.78M
    @ $254.28 · 2025-10-31
    VAN DER VAART SANDRA DILLARD
    Officer
    $1.06M
    @ $271.42 · 2025-08-13
    SCHECHTER ADAM H
    Chief Executive Officer
    $1.51M
    @ $266.78 · 2025-08-11
    GILLILAND DWIGHT GARY
    Director
    $529,900
    @ $264.95 · 2025-07-30
    WILKINSON PETER J
    Officer
    $52,727
    @ $261.02 · 2025-07-29
    ANDERSON KERRII B
    Director
    $980,000
    @ $280.00 · 2025-07-24
    ANDERSON KERRII B
    Director
    $132,500
    @ $265.00 · 2025-07-01
    ANDERSON KERRII B
    Director
    $130,000
    @ $260.00 · 2025-06-11
    CAVENEY BRIAN J
    Officer
    $494,000
    @ $247.00 · 2025-06-03
    SCHECHTER ADAM H
    Chief Executive Officer
    $1.52M
    @ $248.73 · 2025-05-12
    VAN DER VAART SANDRA DILLARD
    Officer
    $452,884
    @ $238.36 · 2025-05-01
    WILKINSON PETER J
    Officer
    $200,838
    @ $242.27 · 2025-05-01
    SCHROEDER MARK S
    Chief Operating Officer
    $610,450
    @ $231.67 · 2025-03-28
    SUMMY AMY B
    Officer
    $175,606
    @ $231.67 · 2025-03-28
    ANDERSON KERRII B
    Director
    $127,817
    @ $255.63 · 2025-03-05
    SCHROEDER MARK S
    President
    $1.33M
    @ $249.23 · 2025-02-28
    VAN DER VAART SANDRA DILLARD
    Officer
    $330,208
    @ $251.30 · 2025-02-25
    SUMMY AMY B
    Officer
    $56,590
    @ $250.40 · 2025-02-24
    WILKINSON PETER J
    Officer
    $347,739
    @ $246.10 · 2025-02-18
    SCHECHTER ADAM H
    Chief Executive Officer
    $1.50M
    @ $244.62 · 2025-02-11
    ANDERSON KERRII B
    Director
    $235,000
    @ $235.00 · 2025-01-07
    EISENBERG GLENN A
    Officer
    $2.82M
    @ $240.43 · 2024-12-02
    GILLILAND DWIGHT GARY
    Director
    $241,000
    @ $241.00 · 2024-12-02
    SUMMY AMY B
    Officer
    $877,142
    @ $238.94 · 2024-11-22
    VAN DER VAART SANDRA DILLARD
    Officer
    $239,419
    @ $239.42 · 2024-11-21
    SCHECHTER ADAM H
    Chief Executive Officer
    $1.51M
    @ $243.47 · 2024-11-11
    ANDERSON KERRII B
    Director
    $230,000
    @ $230.00 · 2024-10-24
    VAN DER VAART SANDRA DILLARD
    Officer
    $454,100
    @ $227.05 · 2024-08-19
    EISENBERG GLENN A
    Chief Financial Officer
    $3.36M
    @ $223.99 · 2024-08-15
    ANDERSON KERRII B
    Director
    $225,000
    @ $225.00 · 2024-08-08
    BERBERIAN LANCE V
    Chief Technology Officer
    $2.77M
    @ $229.10 · 2024-08-05
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
    PFE
    1
    Sells (3M)
    1
    Sells (12M)
    Total value (12M): $51,400
    DAMICO JENNIFER B.
    Officer
    $51,400
    @ $25.70 · 2026-06-09
    DAMICO JENNIFER B.
    Officer
    $64,825
    @ $25.93 · 2025-03-04
    DAMICO JENNIFER B.
    Officer
    $147,714
    @ $28.66 · 2024-08-13
    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

    Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

    🎭 Mr. Market's Mood

    Learn more →
    LH
    FearGreed
    😏Greed(72/100)

    "Market is optimistic — be cautious and ensure you have a margin of safety"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
    PFE
    FearGreed
    😐Neutral(52/100)

    "Market is pricing this stock without strong emotion in either direction"

    Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

    ⚖️ Buffett Signal

    Learn more →
    LH
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Greed (72)
    PFE
    Awaiting DCF Data

    The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

    DCF Margin of Safety: N/AMr. Market's Mood: Neutral (52)
    View LH Full AnalysisView PFE Full Analysis

    Frequently Asked Questions: LH vs PFE

    Is Labcorp Holdings Inc. or Pfizer, Inc. more undervalued in 2026?

    Based on our discounted cash flow model, PFE trades at a 100.0% margin of safety (intrinsic value $127985960274 vs. price $25), compared to LH's -44.9% margin of safety (intrinsic $213 vs. $309).

    Which stock has a wider economic moat, Labcorp Holdings Inc. or Pfizer, Inc.?

    LH scores 52/100 (Narrow moat), while PFE scores 35/100 (None moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

    Is Pfizer, Inc. in financial distress?

    PFE's Altman Z-Score of 1.4 places it in the Distress zone, signaling elevated bankruptcy risk. LH scores 3.0 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

    Which stock has higher return on invested capital, Labcorp Holdings Inc. or Pfizer, Inc.?

    PFE earns 10.2% ROIC versus LH's 9.0%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

    Which dividend is safer, Labcorp Holdings Inc.'s or Pfizer, Inc.'s?

    LH's dividend earns a safety score of 88/100 (Very Safe), compared to PFE's 24/100 (Unsafe). LH has raised its dividend for 1 consecutive years.

    LH vs PFE: Which Is the Better Buy in 2026? | SafetyMargin.io